| Patrick Rask, MD | |
|
800 Ne Circle Blvd, Corvallis, OR 97330-4256 | |
| (541) 286-4742 | |
| (833) 450-5933 |
| Full Name | Patrick Rask |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 30 Years |
| Location | 800 Ne Circle Blvd, Corvallis, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427188309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | MD20927 (Oregon) | Primary |
| 208VP0000X | Pain Medicine - Pain Medicine | MD20927 (Oregon) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Regional Medical Center | Corvallis, OR | Hospital |
| Samaritan Lebanon Community Hospital | Lebanon, OR | Hospital |
| Samaritan Pacific Community Hospital | Newport, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Corvallis Medical Group Llc | 1658500608 | 4 |
News Archive
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer.
In the first national report that compares the health and well-being of children with special health care needs to those children without, findings revealed that 14 to 19 percent of children in the United States have a special health care need, representing more than one in five households with children.
Saint Louis University research shows a new class of drugs may hold promise in treating brain chemical problems such as Alzheimer's disease, says the principal investigator of research published in an early on-line version of Peptides.
AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).
› Verified 5 days ago
| Entity Name | Corvallis Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770912719 PECOS PAC ID: 1658500608 Enrollment ID: O20140214001414 |
News Archive
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer.
In the first national report that compares the health and well-being of children with special health care needs to those children without, findings revealed that 14 to 19 percent of children in the United States have a special health care need, representing more than one in five households with children.
Saint Louis University research shows a new class of drugs may hold promise in treating brain chemical problems such as Alzheimer's disease, says the principal investigator of research published in an early on-line version of Peptides.
AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Rask, MD 800 Ne Circle Blvd, Corvallis, OR 97330-4256 Ph: (541) 286-4742 | Patrick Rask, MD 800 Ne Circle Blvd, Corvallis, OR 97330-4256 Ph: (541) 286-4742 |
News Archive
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer.
In the first national report that compares the health and well-being of children with special health care needs to those children without, findings revealed that 14 to 19 percent of children in the United States have a special health care need, representing more than one in five households with children.
Saint Louis University research shows a new class of drugs may hold promise in treating brain chemical problems such as Alzheimer's disease, says the principal investigator of research published in an early on-line version of Peptides.
AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).
› Verified 5 days ago
Christopher Jason Smith, P.A. Pain Medicine Medicare: Medicare Enrolled Practice Location: 800 Ne Circle Blvd, Corvallis, OR 97330 Phone: 541-286-4742 Fax: 833-450-5933 | |
Dr. Jordan S Garman, D.O. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Ne Circle Blvd, Corvallis, OR 97330 Phone: 541-286-4742 Fax: 833-450-5933 |